Reported Applications: in vivo neutrophil depletion, Immunohistochemistry (paraffin), Immunohistochemistry (frozen), Immunofluorescence, Flow cytometry
Read More
Activation of ILC2 expressed GITR ameliorates type 2 diabetes
Posted in Research Highlights, Featured
Chronic obesity is associated with the development of systemic inflammation and recruitment of inflammatory immune cells to tissues, such as adipose tissue, liver, and muscle. This pro-inflammatory en
Read More
March into News, Research Highlights, and Savings with Bio X Cell
Posted in Monthly Newsletters, Featured
The global source for in vivo antibodies
Read More
The FasL and the Furious - Introducing anti-mouse Fas ligand (CD178)
Posted in Product Highlights, Featured
The MFL3 monoclonal antibody reacts with mouse Fas Ligand (FasL) also known as CD178, CD95 Ligand, and TNFSF6. FasL is a 40 kDa type II transmembrane glycoprotein and a member of the TNF superfamily.
Read More
Melanoma tumors use IFNγ mutations to fight anti-CTLA-4 immunotherapy
Posted in Research Highlights, Featured
Dr. Padmanee Sharma’s group at MD Anderson Cancer Center have discovered that tumor cells use genetic mutations which cause a loss of IFNγ signaling to resist the cancer drug ipilimumab. This study ma
Read More
How do I decide which anti-mouse PD-1 antibody is best for me?
Posted in Product Highlights, Featured
How do I decide which anti-mouse PD-1 antibody is best for me?
Read More
Oxygen sensing by T cells facilitates the establishment of cancer metastasis in the lung
Posted in Research Highlights, Featured
Dr. Nicholas Restifo’s group at the National Cancer Institute's Center for Cancer Research have discovered that oxygen-sensing proteins, called prolyl hydroxylase domain (PHD) proteins, act within T c
Read More
Bio X Cell's Top 20
Posted in Product Highlights, Featured
Bio X Cell invites you to view our top 20 BEST SELLERS of 2018!
Read More
A Novel Immune Checkpoint Inhibitor Anti-NKG2A Antibody Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells
Posted in Research Highlights, Featured
Immune checkpoint inhibitors, in particular anti-PD-1/L1, have revolutionized cancer treatment over the past decade, providing long-lasting benefits.
Read More
Blocking messages carried through brain lymphatic vessels curbs the development of multiple sclerosis
Posted in Research Highlights, Featured
Recently researchers at the University of Virginia, led by Jonathan Kipnis identified lymphatic vessels surrounding the brain, vessels that textbooks long insisted did not exist.
Read More